Neuraxis Board Member Watkins Mitchell Buys $163k in Shares Amid Stock Dip, Signaling Confidence in Upcoming Milestones
Insider buying at Neuraxis shows board confidence, with Watkins Mitchell buying 26k shares as the firm eyes clinical milestones and a potential rebound from $2.21.
3 minutes to read